These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 810837)

  • 41. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clindamycin and metronidazole as independent risk factors for nosocomial acquisition of multidrug-resistant Pseudomonas aeruginosa.
    Cipriano Souza R; Vicente AC; Vieira VV; Marques SG; Soares Md; Moura MC; Koifman RJ
    J Hosp Infect; 2008 Aug; 69(4):402-3. PubMed ID: 18511147
    [No Abstract]   [Full Text] [Related]  

  • 43. Sepsis in a newborn due to Pseudomonas aeruginosa from a contaminated tub bath.
    Vochem M; Vogt M; Döring G
    N Engl J Med; 2001 Aug; 345(5):378-9. PubMed ID: 11484709
    [No Abstract]   [Full Text] [Related]  

  • 44. Fatal multi-resistant Pseudomonas aeruginosa septicemia outbreak in a neonatal intensive care unit in Trinidad.
    Orrett FA
    Ethiop Med J; 2000 Apr; 38(2):85-91. PubMed ID: 11144887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [An epidemiological study of Pseudomonas aeruginosa infection. An epidemiological study of the clinical and environmental strains in the urological field (author's transl)].
    Kamada H
    Nihon Hinyokika Gakkai Zasshi; 1979 Oct; 70(10):1142-58. PubMed ID: 118296
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections.
    Schutze GE; Gilliam CH; Jin S; Cavenaugh CK; Hall RW; Bradsher RW; Jacobs RF
    Pediatr Infect Dis J; 2004 Feb; 23(2):110-4. PubMed ID: 14872174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Epidemiologic markers in the study of Pseudomonas aeruginosa from a pediatric intensive care unit].
    Azahares Ramírez L; Pérez Monrás M; Rodríguez González D; Zuazo Silva J
    Rev Cubana Med Trop; 1991; 43(2):132-5. PubMed ID: 1812531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of antimicrobial agents on Pseudomonas aeruginosa strains isolated from sporadical cases and nosocomial infections.
    Meitert E; Sima F; Savulian C; Chersulick E; Petrescu AM
    Arch Roum Pathol Exp Microbiol; 1988; 47(3-4):227-38. PubMed ID: 3150919
    [No Abstract]   [Full Text] [Related]  

  • 49. Predominance of Pseudomonas aeruginosa serotype 11, pyocin types 1 and 10 in Singapore.
    Poh CL; Yap EH; Tay L; Loh GK; Thong TW
    Singapore Med J; 1986 Apr; 27(2):135-9. PubMed ID: 3092359
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit.
    Mayank D; Anshuman M; Singh RK; Afzal A; Baronia AK; Prasad KN
    Indian J Pathol Microbiol; 2009; 52(4):509-13. PubMed ID: 19805958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pseudomonas aeruginosa infections in a premature infant center in the years 1960 to 1963].
    Monnet P; Chassignol S; Vaillaud JC
    Arch Fr Pediatr; 1967 May; 24(5):543-54. PubMed ID: 4293868
    [No Abstract]   [Full Text] [Related]  

  • 53. Contamination and survival of Pseudomonas aeruginosa in hospital used sponges.
    Oie S; Kamiya A
    Microbios; 2001; 105(412):175-81. PubMed ID: 11414502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006.
    Patzer JA; Walsh TR; Weeks J; Dzierzanowska D; Toleman MA
    J Antimicrob Chemother; 2009 Feb; 63(2):269-73. PubMed ID: 19095681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
    Sidorenko SV; Gel'fand EB; Mamontova OA
    Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiological study of Pseudomonas aeruginosa isolated from clinical specimens.
    Srifuengfung S; Thanagrumetha W
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):444-8. PubMed ID: 8160050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pseudomonas aeruginosa infections].
    Steiner B; Putnoky G; Dobos A
    Monatsschr Kinderheilkd (1902); 1969 Dec; 117(12):660-5. PubMed ID: 4320625
    [No Abstract]   [Full Text] [Related]  

  • 58. [Isolation of a Pseudomonas aeruginosa strain with a R plasmide from the case of nosocomial infection (author's transl)].
    Procházková A; Vacek V; Hústavová H; Krcméry V
    Cesk Epidemiol Mikrobiol Imunol; 1977 Jan; 26(1):41-5. PubMed ID: 140013
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pseudomonas aeruginosa infection in patients with thermal lesions].
    Grishina IA; Panova IuM; Akatova NS; Smirbova NE; Minkova GL
    Klin Med (Mosk); 1978 Jul; 56(7):117-22. PubMed ID: 98664
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cross infection due to Pseudomonas aeruginosa and the countermeasures].
    Funada H
    Nihon Naika Gakkai Zasshi; 1993 Aug; 82(8):1182-7. PubMed ID: 7693836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.